Company / Net Income
iBio, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$24.9M
FY2025
5-year range
-$65.0M / -$16.4M
FY2021-FY2025
Trend
+61.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income returned to growth in FY2025 after 3 years of decline, reaching -$25M.
Based on SEC 10-K filings.
-$25M in FY2025.
Improved from -$50M to -$25M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 61.7% year-over-year.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$24.9M | +61.7% |
| FY2024 | -$65.0M | -29.2% |
| FY2023 | -$50.3M | -116.8% |
| FY2022 | -$23.2M | -41.2% |
| FY2021 | -$16.4M | +6.6% |
| FY2020 | -$17.6M | -9.2% |
| FY2019 | -$16.1M | -10.8% |
| FY2018 | -$14.5M | -48.8% |
| FY2017 | -$9.8M | -47.4% |
| FY2016 | -$6.6M | -80.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026